Luminex Corporation (NASDAQ:LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance on Friday, June 28, 2019. The assay is a real-time, quantitative polymerase chain reaction (qPCR)-based, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization.
insider ownership percentage is the key indicator, can be used by investors, to
measure the outlook of senior management has on their company. Insider
ownership for the LMNX is 3.70%. Institutional ownership refers to the
ownership stake in a company that is held by large financial organizations,
pension funds or endowments. The Institutional ownership for the LMNX is
Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that LMNX. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Luminex Corporation (NASDAQ:LMNX) is 0.00%.
Institutional ownership is the amount of a Luminex Corporation (NASDAQ:LMNX)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the LMNX is 0.79%.
a Healthcare sector firm, Luminex Corporation (NASDAQ:LMNX) stock climbs 0.15% on Monday and when day-trade ended the stock finally concluded at $20.67 and number of shares that changed hands during the day are 238825. The number of shares LMNX stock currently held by all its shareholders are 44.28 and floated shares, the number of shares are available for trading in an open market on last trading day are 42.75. The average volume of shares for 3 months is 284.68 and LMNX stock value has moved between $20.07 – 35.64 in last one year.
The Luminex Corporation (NASDAQ:LMNX)’s latest earnings date is 8/5/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Luminex Corporation (NASDAQ:LMNX) is 59.50% and the stock has gained -10.56% in 2019 to date.
U.S. traded shares of Luminex Corporation
(NASDAQ:LMNX)’s monthly stock performance is -2.04%, the quarterly performance
is -10.87%, the half year performance is calculated as -10.75%. The yearly
performance of LMNX is -28.43%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Luminex Corporation (NASDAQ:LMNX) weekly volatility is measured as 2.07% and monthly volatility measured as 2.15%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. LMNX return on investment is calculates as a percentage and is typically used for personal financial decisions, and LMNX return on investment is 2.40%.
The price to earnings ratio is 234.89, price to sales ratio is 2.90, and price to book ratio is 1.94, price to cash per share ration is 14.83.
Analysts mean target price for Luminex Corporation (NASDAQ:LMNX) is $28.25 while analysts mean recommendation is 2.70. The current share price indicates that stock is -41.56% away from its one year high and is moving 3.30% ahead of its 52-week low. LMNX’s distance from 20 day simple moving average is -2.26% and distance from 50-Day simple moving average is -4.16%.